The GLP-1 patient: Why more are turning to aesthetic providers Many patients today are experiencing the fastest weight loss of their lives, and for a large percentage, semaglutide is their first-ever aesthetic or wellness treatment
And, for us, five years is only the beginning
For a 220 pound patient, that translates to roughly 7 additional pounds lost over the treatment period
65 years), baseline eGFR ( 40%), treatment with 10 mg empagliflozin for a median time of 26.2 months reduced the risk of a composite of CV death or hospitalization for HF by 21%, and effect which was mainly related to a 29% lower risk of hospitalization for HF
Conflict of interest This study received funding from Alfasigma S.p.A
Compounded GLP-1 + GIP Treatment Plan (Tirzepatide) For some California patients, licensed providers may consider a medical weight loss program that incorporates compounded GLP-1 + GIPbased treatment plans